510(k) Clearance for the Arrow® VPS Rhythm™
Device expands Teleflex’s Catheter Tip Navigation and Placement
portfolio to now include familiar ECG-only technology for the
elimination of chest X-ray
WAYNE, Pa.--(BUSINESS WIRE)--Jan. 10, 2017--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
technologies for critical care and surgery, has announced that its Arrow®
VPS Rhythm™ Device with Optional TipTracker™ Technology has been issued
510(k) Clearance to commercialize the device in the United States.
The Arrow® VPS Rhythm™ Device is a
simple and versatile solution that provides ECG-based tip confirmation
in a highly portable and lightweight design.
The Arrow® VPS Rhythm™ Device
assists in placement and confirmation of a catheter tip in the SVC-CAJ
(superior vena-cava-cavoatrial junction); it may be used with a broad
range of catheter types and brands. Intravascular P-wave changes are
saved as the catheter approaches the SVC, helping to identify the lower
1/3 of the SVC, near the CAJ, eliminating the need for confirmatory
chest X-ray or fluoroscopy in adult patients. When paired with the
single-use TipTracker™ Stylet for insertion of peripherally-inserted
central catheters (PICCs), the Arrow® VPS Rhythm™
Device provides real-time visual navigation by tracing the catheter
pathway with a blue line on a color screen. The Device has an expansive
sphere of visual navigation to provide easy navigation of the PICC
during insertion.
“This clearance positions us to provide catheter tip placement solutions
that meet customer’s unique therapeutic and budgetary needs,” said Jay
White, president and general manager, Vascular Division of Teleflex.
“The VPS Rhythm™ Device with Optional TipTracker™ Technology will
complement our existing Arrow® VPS G4™ Device, diversifying
and strengthening our catheter tip positioning portfolio globally. Most
importantly, it furthers our goal of making products that simplify
clinician’s work and improve a patient's care.”
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation – a relentless pursuit of identifying unmet clinical
needs – to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference. For more
information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson
RCI®, LMA®, Pilling®, Rusch®
and Weck® – trusted brands united by a common sense of
purpose.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA,
Pilling, Rusch, TipTracker, VPS Rhythm and Weck are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates, in the
U.S. and/or other countries. All other trademarks are trademarks of
their respective owners.
© 2017 Teleflex Incorporated. All rights reserved. MC-002962
View source version on businesswire.com: http://www.businesswire.com/news/home/20170110005044/en/
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836